NCT02798276Completed
Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
The purpose of this trial is to evaluate the efficacy of a pericardial adipose graft transposition (Adipose Graft Trasposition Procedure, AGTP) for the improvement of cardiac function in patients with a chronic myocardial infarction. Preclinical studies in the porcine model of myocardial infarction have shown that the AGTP reduces infarct area and improves cardiac function. A first-in-man clinical (NCT01473433) trial showed that the AGTP is safe in patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 26 May 2016
- Start date
- 1 Mar 2017
- Primary completion date
- 20 Nov 2025
- Lead sponsor
- Antoni Bayés Genís
- Diseases
- Coronary artery disease
- NCT number
- NCT02798276
What you commit to
- Study type: Interventional
- Participants enrolled: 71
- From 1 Mar 2017 to the primary completion date, 20 Nov 2025
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous cardiac intervention
Other illness
- Severe non cardiac co-morbidity with a reduction of life expectancy of less than 1 year
- Severe valvular disease candidate for surgical restoration
- Severe renal or hepatic failure
Lab values
- Abnoraml laboratory tests (no explanation at inclusion)
Other
- Candidate to ventricular remodeling
- Contraindication for NMR
- Pregnant or breast feeding women
Who the study is looking for
- \> 18 years of age, capable of giving informed consent.
- Q wave in the ECG
- Myocardial infarct \>=50% transmularity by NMR non revascularizable (for transmurality or bad vessel).
- Candidate to bypass for other myocardial areas
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Germans Trias University Hospital; Germans Trias Research Institute Coordinator of this site? Confirm its status | Badalona | Spain | Unknown status |
| Hospital General Universitario Gregorio Marañón Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Hospital Universitario Puerta de Hierro Coordinator of this site? Confirm its status | Majadahonda | Spain | Unknown status |
| Hospital Virgen de la Victoria Coordinator of this site? Confirm its status | Málaga | Spain | Unknown status |
| Hospital Clínico Universitario Virgen de la Arrixaca Coordinator of this site? Confirm its status | Murcia | Spain | Unknown status |
| Hospital Universitario Central De Asturias Coordinator of this site? Confirm its status | Oviedo | Spain | Unknown status |
| Son Espases Hospital Coordinator of this site? Confirm its status | Palma de Mallorca | Spain | Unknown status |
| Hospital Clinico Universitario de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Hospital Clínico Universitario de Valladolid Coordinator of this site? Confirm its status | Valladolid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.